Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study

Clinical trial NCT03775538 · COMPLETED

Trial details

NCT number: NCT03775538
Sponsor: Herantis Pharma Plc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Parkinson Disease Movement Disorders Neuro-Degenerative Disease Nervous System Diseases Brain Diseases

Start date: 2018-07-05
Primary completion: 2020-07-08
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.